As site head of Bayer’s U.S. innovation center in Mission Bay, Hermiston oversees 80 people focused on hematology, cardiology, oncology, women’s health care and diagnostic imaging research. Hermiston came to Bayer in its 2007 acquisition of Schering/Berlex, where he oversaw gene technologies.
No comments:
Post a Comment